Aprameya EngineeringNSE:APRAMEYA +3.06%41 Days Payable is 259.52 as of Mar. 2026, which is 196% above its 10-year median of 87.59. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 41/100. The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Aprameya Engineering ranks better than 87.04% on this metric.
The historical rank and industry rank for Aprameya Engineering's Days Payable or its related term are showing as below:
NSE:APRAMEYA'
s Days Payable Range Over the Past 10 Years
Min: 26.34 Med: 87.59 Max: 268.78
Current: 259.52
During the past 7 years, Aprameya Engineering's highest Days Payable was 268.78. The lowest was 26.34. And the median was 87.59.
NSE:APRAMEYA's Days Payable is ranked better than 87.04% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs NSE:APRAMEYA: 259.52
Aprameya Engineering's Days Payable
increased
from Mar. 2024 (56.42) to Mar. 2026 (259.52).
It may suggest that Aprameya Engineeringdelayed paying its suppliers.
Aprameya Engineering Days Payable Related Terms
Aprameya Engineering Days Payable Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's Days Payable distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Aprameya Engineering's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aprameya Engineering (NSE:APRAMEYA) has a Days Payable of 259.52 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aprameya Engineering and its competitors. This is 196% above median its historical median of 87.59. Over the past decade, Aprameya Engineering's Days Payable has ranged from 26.34 to 268.78. According to the industry distribution chart, Aprameya Engineering ranks #103 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 13%.
Is Aprameya Engineering's Days Payable too high?
Aprameya Engineering's current Days Payable of 259.52 is 196% above median its 10-year median of 87.59. Over the past 10 years, this metric has ranged from a low of 26.34 to a high of 268.78. The Medical Devices & Instruments industry median Days Payable is 68.07. Aprameya Engineering's value of 259.52 is 281.3% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #103 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aprameya Engineering has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #103 out of 795 companies for Days Payable. This places Aprameya Engineering in the top 13% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Aprameya Engineering's value of 259.52 is 281.3% above this benchmark. Historically, Aprameya Engineering's own Days Payable has ranged from 26.34 to 268.78 over the past decade. While the company's 10-year median is 87.59 vs. the industry median of 68.07, Aprameya Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current Days Payable of 259.52 is 281.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current Days Payable is 259.52, which is 196% above median its own 10-year median of 87.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current Days Payable of 259.52. The current Days Payable is 259.52, which is 196% above median its 10-year median of 87.59 and 281.3% above the Medical Devices & Instruments industry median of 68.07. Aprameya Engineering's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current Days Payable is 259.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
41GF Score
Get the complete analysis for NSE:APRAMEYA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 